Asthma Market Outlook - Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie
Asthma Market Outlook – Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie
Stay updated with breaking news from Eleusis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asthma Market Outlook – Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie
Asthma Market Outlook – Post Covid-19 Scenario | AstraZeneca, Amgen, Genentech, AbbVie
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.
Published: Jun 03, 2021 By Alex Keown 180 Life Sciences -- Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Of...
Opthea Appoints Julia A. Haller, MD, and Judith Robertson to Board of Directors - read this article along with other careers information, tips and advice on BioSpace